Cancer Invest March 2021 PMID 33534645

Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer.

Nicole M Kuderer, Joshua A Hill, Paul A Carpenter, Gary H Lyman

Mentions

7
Peak: 4 in Feb 2021
across 3 sources since Feb 2021

Extended reach

4,877
potential audience

Total likes

21

Video views

1,490

Mentions per month

Feb 2021 – Mar 2021

Where it's discussed

  • X / Twitter4 posts
  • YouTube2 videos
  • News1 articles

AI synopsis

What people are saying

The collective discussion demonstrates strong agreement with the publication, as evident in statements like 'Cancer patients are a high risk population' and the emphasis on vaccination prioritization. The tone and choice of words, such as 'high risk' and 'should be prioritized,' reflect the perceived importance and urgency of protecting vulnerable patients, contributing to a view that these social discussions could influence healthcare practices.

AgreementStrong agreement

Most discussions strongly agree with the article, emphasizing that cancer patients should be prioritized for vaccination.

InterestHigh interest

Posts show high interest, referencing specific authors and the importance of vaccination in vulnerable groups.

EngagementModerate engagement

While one post directly supports the publication, the engagement remains moderate due to limited diversity of responses.

ImpactHigh impact

The focus on prioritization and protection highlights that these discussions have significant implications for health policy and patient care.

Abstract in brief

  • Patients with cancer are at higher risk for severe COVID-19, highlighting the urgent need for safe and effective vaccines.
  • Evidence suggests most cancer patients should receive COVID-19 vaccines, but careful monitoring of safety and effectiveness in this group is essential.
  • Special attention is needed for patients undergoing active treatment, with ongoing research to assess the timing and impact of vaccination in relation to cancer therapies.]

Top posts

Most liked on X and Bluesky
Diego Adrianzen-Herrera, MD, MS
@diegoah66 · X

Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Commentary by ⁦@NicoleKuderer⁩ ⁦@gary_lyman⁩

Feb 21, 2021 · 2 likes · 2 shares · 620 followers View post →
Raffaele Giusti
@oncoblogger · X

Challenges and Opportunities for #COVID19 #Vaccines in Patients with #Cancer https://t.co/3g7ZdqN89c

Feb 22, 2021 · 1 like · 1,517 followers View post →
Krishan Maggon
@kkmaggon · X

Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer https://t.co/tUi1BmBZUw

Feb 22, 2021 · 1,001 followers View post →
Veronica Davalos
@VeroDavalosVega · X

RT @diegoah66: Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Com…

Feb 22, 2021 · 2 shares · 232 followers View post →

All mentions

Krishan Maggon
@kkmaggon · X

Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer https://t.co/tUi1BmBZUw

Feb 22, 2021 · 1,001 followers View post →
Veronica Davalos
@VeroDavalosVega · X

RT @diegoah66: Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Com…

Feb 22, 2021 · 2 shares · 232 followers View post →
Raffaele Giusti
@oncoblogger · X

Challenges and Opportunities for #COVID19 #Vaccines in Patients with #Cancer https://t.co/3g7ZdqN89c

Feb 22, 2021 · 1 like · 1,517 followers View post →
Diego Adrianzen-Herrera, MD, MS
@diegoah66 · X

Cancer patients are a high risk population for #COVID-19 complications and should be prioritized to receive the vaccine. Commentary by ⁦@NicoleKuderer⁩ ⁦@gary_lyman⁩

Feb 21, 2021 · 2 likes · 2 shares · 620 followers View post →
COVID-19 Cancer Registry Insights | PDF | Hematopoietic Stem Cell ...
News

Published online February 3, 2021:1–19. doi:10.1080/07357907.2021.1885596 15. Lyman GH, Kuderer NM. Randomized Controlled Trials Versus Real-World Data in ...

Dec 14, 2025 View →